Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our researchers are tackling the devastating brain condition encephalitis.

© John Cairns

Tuesday 22 February was World Encephalitis Day, and the Ashmolean Museum in Oxford took part in 'Light up a Landmark' to help raise awareness right across the world. 

Researchers Sofija Paneva, Laurissa Havins and Christine Strippel from the Oxford Autoimmune Neurology Group outside the Ashmolean Museum lit up red for World Encephalitis Day 2023 © John Cairns

Encephalitis is an inflammation of the brain. It is caused by an infection or the immune system attacking the brain in error. It can have a high death rate and survivors might be left with an acquired brain injury and life-changing consequences. Early diagnosis and treatment can save lives and improve outcomes.

Professor Sarosh Irani leads our Autoimmune Neurology Group. They work with patients and their carers, to better understand diagnosis, the underlying cause of the diseases and patient outcomes. 

The team is also involved in improving awareness of encephalitis among the general public and fellow healthcare professionals in the hope that it can eventually lead to a quicker pathway for patients to get the care they need.

Pictured are researchers Sofija Paneva, Laurissa Havins and Christine Strippel.

Read more on the University of Oxford website.

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Meeting the neuroscientists at Meeting Minds

Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.